
Core Insights - Synergy CHC Corp. reported a 30% year-over-year growth in earnings per share, marking its ninth consecutive quarter of profitability [2] - The company expanded its EBITDA margins to 24.1%, up from 19.7% in the prior year, indicating strong operational performance [2] - Synergy is preparing for international expansion into three new markets and is refinancing its debt to enhance cash flow and extend maturity to 2029 [2] Financial Performance - Revenue for Q1 2025 was $8.2 million, a decrease of 13% from $9.4 million in Q1 2024, primarily due to a non-repeating product sell-in [5] - Gross margin improved to 75.4% from 72.0% year-over-year, driven by a favorable product mix [5] - Operating expenses decreased by 15% to $4.2 million from $5.0 million in the same period last year [6] - Income from operations increased by 8% to $1.9 million compared to $1.8 million in Q1 2024 [6] - Net income rose by 51% to $876.3 thousand from $580.5 thousand year-over-year [7] - EBITDA for Q1 2025 was $1.98 million, up 7% from $1.85 million in Q1 2024, attributed to lower SG&A expenses [7] Balance Sheet and Cash Flow - As of March 31, 2025, cash and cash equivalents were approximately $177.9 thousand, down from $687.9 thousand at the end of 2024 [10] - Total liabilities decreased to $31.3 million from $33.0 million, reflecting a reduction of $1.7 million [10] - Inventory increased to $2.3 million from $1.7 million as of December 31, 2024 [10] - Cash used in operating activities was $822.8 thousand, slightly improved from $858 thousand in Q1 2024 [11] Business Developments - Synergy established a wholly owned subsidiary in Mexico and is onboarding key suppliers and retailers in the region [9] - The company signed a new long-term supplier agreement for FOCUSfactor products, effective April 2025, expected to yield significant cost savings [9] - During Q1, Synergy reduced outstanding liabilities by $1.7 million [9]